论文部分内容阅读
1872年Kaposi氏首先描述本病为一种特发性、多灶性色素沉着的皮肤肉瘤,临床罕见。过去主要见于欧洲、北美的意大利、犹太和斑图族血统的老年男子中,称经典型卡氏肉瘤。在非洲乌干达、札伊尔、肯尼亚等相当于Burkitt氏淋巴瘤流行地区好发卡氏肉瘤,约占该地区肿瘤发病的9％;其中部份恶性程度高、发展快、波及内脏和淋巴结,多在发病后2～3年内死亡。称非洲型卡氏肉瘤,此型见于黑非洲儿童和青年。此外在肾
In 1872 Kaposi first described the disease as an idiopathic, multifocal pigmented cutaneous sarcoma, rare in clinical practice. In the past, elderly men of Italian, Jewish, and tabulae origin, mainly found in Europe and North America, were referred to as Classic Kaposi’s sarcoma. In Africa, Uganda, Zaire, Kenya, etc. Corresponding to the Burkitt’s lymphoma endemic area, Caesar’s sarcoma is well developed, accounting for about 9% of the tumor incidence in the region; some of them have high degree of malignancy, rapid development, spread to internal organs, and lymph nodes. Death within 2 to 3 years after onset. Called African Kaposi’s sarcoma, this type is seen in black African children and youth. In addition to kidney